VSC4.1 Cells

VSC4.1 is a hybrid motor neuron-like cell line generated by somatic fusion of embryonic rat ventral spinal cord neurons with the mouse neuroblastoma cell line N18TG2. The resulting hybridoma retains morphological and biochemical properties of spinal motor neurons while exhibiting the proliferative capacity conferred by the neuroblastoma partner. VSC4.1 cells grow adherently and display neuron-like morphology with phase-bright cell bodies and extending neurite-like processes under appropriate culture conditions. The line has been widely adopted as an in vitro model of lower motor neurons.

Molecular characterization demonstrates that VSC4.1 cells express multiple motor neuron-associated markers, including choline acetyltransferase (ChAT), confirming their cholinergic phenotype. They also express neurofilament proteins and other neuronal cytoskeletal components consistent with differentiated neuronal identity. Under differentiating conditions, such as serum reduction or treatment with cyclic AMP analogs or retinoic acid, VSC4.1 cells exhibit enhanced neurite outgrowth and increased expression of neuronal markers, supporting their utility for studying neuronal differentiation and axonal biology.

VSC4.1 cells are extensively used to investigate mechanisms of motor neuron injury and degeneration, including oxidative stress, excitotoxicity, mitochondrial dysfunction, and apoptosis. They serve as a commonly employed in vitro model for amyotrophic lateral sclerosis (ALS)-related research, particularly in studies examining SOD1-associated toxicity, calcium dysregulation, and neuroprotective interventions. The combination of motor neuron-like phenotype and robust in vitro growth makes VSC4.1 a valuable system for mechanistic studies of spinal motor neuron pathology and therapeutic screening.